215 related articles for article (PubMed ID: 17804720)
1. Requirement for Rac1 in a K-ras induced lung cancer in the mouse.
Kissil JL; Walmsley MJ; Hanlon L; Haigis KM; Bender Kim CF; Sweet-Cordero A; Eckman MS; Tuveson DA; Capobianco AJ; Tybulewicz VL; Jacks T
Cancer Res; 2007 Sep; 67(17):8089-94. PubMed ID: 17804720
[TBL] [Abstract][Full Text] [Related]
2. The Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesis.
Zhou C; Licciulli S; Avila JL; Cho M; Troutman S; Jiang P; Kossenkov AV; Showe LC; Liu Q; Vachani A; Albelda SM; Kissil JL
Oncogene; 2013 Feb; 32(7):903-9. PubMed ID: 22430205
[TBL] [Abstract][Full Text] [Related]
3. K-Ras mediated murine epidermal tumorigenesis is dependent upon and associated with elevated Rac1 activity.
Samuel MS; Lourenço FC; Olson MF
PLoS One; 2011 Feb; 6(2):e17143. PubMed ID: 21358804
[TBL] [Abstract][Full Text] [Related]
4. Loss of RhoA Exacerbates, Rather Than Dampens, Oncogenic K-Ras Induced Lung Adenoma Formation in Mice.
Zandvakili I; Davis AK; Hu G; Zheng Y
PLoS One; 2015; 10(6):e0127923. PubMed ID: 26030593
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase induction of Rac1b, a key effector of lung cancer progression.
Stallings-Mann ML; Waldmann J; Zhang Y; Miller E; Gauthier ML; Visscher DW; Downey GP; Radisky ES; Fields AP; Radisky DC
Sci Transl Med; 2012 Jul; 4(142):142ra95. PubMed ID: 22786680
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras.
Wislez M; Spencer ML; Izzo JG; Juroske DM; Balhara K; Cody DD; Price RE; Hittelman WN; Wistuba II; Kurie JM
Cancer Res; 2005 Apr; 65(8):3226-35. PubMed ID: 15833854
[TBL] [Abstract][Full Text] [Related]
7. Rac1 is crucial for Ras-dependent skin tumor formation by controlling Pak1-Mek-Erk hyperactivation and hyperproliferation in vivo.
Wang Z; Pedersen E; Basse A; Lefever T; Peyrollier K; Kapoor S; Mei Q; Karlsson R; Chrostek-Grashoff A; Brakebusch C
Oncogene; 2010 Jun; 29(23):3362-73. PubMed ID: 20383193
[TBL] [Abstract][Full Text] [Related]
8. Requirement of the NF-kappaB subunit p65/RelA for K-Ras-induced lung tumorigenesis.
Bassères DS; Ebbs A; Levantini E; Baldwin AS
Cancer Res; 2010 May; 70(9):3537-46. PubMed ID: 20406971
[TBL] [Abstract][Full Text] [Related]
9. Conditional expression of the mutant Ki-rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model.
Floyd HS; Farnsworth CL; Kock ND; Mizesko MC; Little JL; Dance ST; Everitt J; Tichelaar J; Whitsett JA; Miller MS
Carcinogenesis; 2005 Dec; 26(12):2196-206. PubMed ID: 16051643
[TBL] [Abstract][Full Text] [Related]
10. An essential role for Rac in Ras transformation.
Qiu RG; Chen J; Kirn D; McCormick F; Symons M
Nature; 1995 Mar; 374(6521):457-9. PubMed ID: 7700355
[TBL] [Abstract][Full Text] [Related]
11. Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma.
Allen TD; Rodriguez EM; Jones KD; Bishop JM
Cancer Res; 2011 Sep; 71(18):6010-8. PubMed ID: 21803744
[TBL] [Abstract][Full Text] [Related]
12. Early requirement of Rac1 in a mouse model of pancreatic cancer.
Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT
Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285
[TBL] [Abstract][Full Text] [Related]
13. The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancer.
Jin K; Park S; Ewton DZ; Friedman E
Cancer Res; 2007 Aug; 67(15):7247-55. PubMed ID: 17671193
[TBL] [Abstract][Full Text] [Related]
14. Temporal dissection of K-ras(G12D) mutant in vitro and in vivo using a regulatable K-ras(G12D) mouse allele.
Wang Z; Feng Y; Bardeesy N; Wong KK; Liu XY; Ji H
PLoS One; 2012; 7(5):e37308. PubMed ID: 22606359
[TBL] [Abstract][Full Text] [Related]
15. K-ras mutations in lung tumors and tumors from other organs are consistent with a common mechanism of ethylene oxide tumorigenesis in the B6C3F1 mouse.
Hong HH; Houle CD; Ton TV; Sills RC
Toxicol Pathol; 2007 Jan; 35(1):81-5. PubMed ID: 17325976
[TBL] [Abstract][Full Text] [Related]
16. Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas.
Tran PT; Fan AC; Bendapudi PK; Koh S; Komatsubara K; Chen J; Horng G; Bellovin DI; Giuriato S; Wang CS; Whitsett JA; Felsher DW
PLoS One; 2008 May; 3(5):e2125. PubMed ID: 18461184
[TBL] [Abstract][Full Text] [Related]
17. Rac1 and extracellularly regulated kinase activation are sufficient for E1A-dependent cooperative transformation of primary epithelial cells, but progression can only be modulated by E1A or Rac1.
Fischer RS; Zheng Y; Quinlan MP
Cell Growth Differ; 1998 Mar; 9(3):209-21. PubMed ID: 9543387
[TBL] [Abstract][Full Text] [Related]
18. A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.
Wang Y; Zhang Z; Lubet RA; You M
Oncogene; 2006 Feb; 25(8):1277-80. PubMed ID: 16247444
[TBL] [Abstract][Full Text] [Related]
19. Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis.
Wang Y; Lebowitz D; Sun C; Thang H; Grynpas MD; Glogauer M
J Bone Miner Res; 2008 Feb; 23(2):260-70. PubMed ID: 17922611
[TBL] [Abstract][Full Text] [Related]
20. Rac GTPase isoforms Rac1 and Rac2 play a redundant and crucial role in T-cell development.
Guo F; Cancelas JA; Hildeman D; Williams DA; Zheng Y
Blood; 2008 Sep; 112(5):1767-75. PubMed ID: 18579797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
